Recruiting Myeloproliferative Neoplasms Studies in Whittier
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2, for the treatment of patients with myelofibrosis (MF) who no longer benefit from treatment with a JAK inhibitor. Inhibition...
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis
This study evaluates either KRT-232 or TL-895 in treatment naïve patients with myelofibrosis (MF) The study will be conducted in 2 stages. Stage 1 will evaluate safety, tolerability, and efficacy of ...
About Myeloproliferative Neoplasms Clinical Trials in Whittier
Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.
There are currently 2 myeloproliferative neoplasms clinical trials recruiting participants in Whittier, CALIFORNIA. These studies are seeking a combined 437 participants. Research is being sponsored by Kartos Therapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myeloproliferative Neoplasms Clinical Trials in Whittier — FAQ
Are there myeloproliferative neoplasms clinical trials in Whittier?
Yes, there are 2 myeloproliferative neoplasms clinical trials currently recruiting in Whittier, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Whittier?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Whittier research site will contact you about next steps.
Are clinical trials in Whittier free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Whittier studies also compensate for your time and travel.
What myeloproliferative neoplasms treatments are being tested?
The 2 active trials in Whittier are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.
Data updated March 2, 2026 from ClinicalTrials.gov